Transfer, Consent to Transfer, Amendment and Assumption of License AgreementAssumption of License Agreement • October 26th, 2005 • Aries Ventures Inc • Metal mining
Contract Type FiledOctober 26th, 2005 Company IndustryThis Transfer, Consent to Transfer, Amendment and Assumption of License Agreement (“Transfer & Assumption Agreement”), effective as of August 31, 2005(the “Effective Date”), is entered into by and among Yale University, a corporation organized and existing under and by virtue of a charter granted by the general assembly of the Colony and State of Connecticut (“Licensor”), Schering Aktiengesellschaft, a German corporation (“Transferor”), and Cardium Therapeutics, Inc., a Delaware Corporation (“Transferee”), each a Party, collectively Parties hereto, in each case including its respective corporate affiliates, successors and assigns.
Transfer, Consent to Transfer, Amendment and Assumption of License AgreementAssumption of License Agreement • October 26th, 2005 • Aries Ventures Inc • Metal mining
Contract Type FiledOctober 26th, 2005 Company IndustryThis Transfer, Consent to Transfer, Amendment and Assumption of License Agreement (“Transfer & Assumption Agreement”), effective as of August 31, 2005 (the “Effective Date”), is entered into by and among New York University, a corporation organized and existing under the laws of the State of New York (“Licensor”), Collateral Therapeutics, Inc., a Delaware corporation (“Transferor”), and Cardium Therapeutics, Inc., a Delaware Corporation (“Transferee”), each a Party, collectively Parties hereto.
Transfer, Consent to Transfer, Amendment and Assumption of License AgreementAssumption of License Agreement • October 26th, 2005 • Aries Ventures Inc • Metal mining
Contract Type FiledOctober 26th, 2005 Company IndustryThis Transfer, Consent to Transfer, Amendment and Assumption of License Agreement (“Transfer & Assumption Agreement”), effective as of July 31, 2005 (the “Effective Date”), is entered into by and among the Regents of the University of California, a California corporation (“Licensor”), Collateral Therapeutics, Inc., a Delaware corporation (“Transferor”), and Cardium Therapeutics, Inc., a Delaware Corporation (“Transferee”), each a Party, collectively Parties hereto, in each case including its respective corporate affiliates, successors and assigns.